These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2213427)

  • 1. Application of improved standardization methods and instrumentation in the USP particulate test for SVI.
    Barber TA; Lannis MD; Williams JG; Ryan JF
    J Parenter Sci Technol; 1990; 44(4):185-203. PubMed ID: 2213427
    [TBL] [Abstract][Full Text] [Related]  

  • 2. USP perspectives on particle contamination of injectable products.
    Gallelli JF; Groves MJ
    J Parenter Sci Technol; 1993; 47(6):289-92. PubMed ID: 8120733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Particulate-matter content of 11 cephalosporin injections: conformance with USP limits.
    Parkins DA; Taylor AJ
    Am J Hosp Pharm; 1987 May; 44(5):1111-8. PubMed ID: 3605122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of methods for detection of particulate matter in large-volume perenterals.
    Blanchard J; Thompson CM; Schwartz JA
    Am J Hosp Pharm; 1976 Feb; 33(2):144-50. PubMed ID: 1258874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new coincidence model for single particle counters, Part I: Theory and experimental verification.
    Knapp JZ; Abramson LR
    J Pharm Sci Technol; 1994; 48(3):110-34. PubMed ID: 8069513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Method evaluation: automated microscopy as a compendial test for particulates in parenteral solutions.
    Barber TA; Lannis MD; Williams JG
    J Parenter Sci Technol; 1989; 43(1):27-47. PubMed ID: 2926604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evaluation of sizing accuracy of particle counters for parenteral drugs.
    Fujishita O; Sendo T; Hisazumi A; Otsubo K; Aoyama T; Oishi R
    PDA J Pharm Sci Technol; 1995; 49(6):267-71. PubMed ID: 8581457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Particulate matter test in small volume parenterals: critical aspects in sampling methodology.
    Pavanetto F; Conti B; Genta I; Ponci R; Montanari L; Grassi M
    Farmaco; 1989 Jun; 44(6):633-43. PubMed ID: 2803449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmaceutical feasibility of sub-visible particle analysis in parenterals with reduced volume light obscuration methods.
    Hawe A; Schaubhut F; Geidobler R; Wiggenhorn M; Friess W; Rast M; de Muynck C; Winter G
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1084-7. PubMed ID: 23454051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the influence of open and closed-ampoule technologies on particulate matter in small-volume parenterals.
    Bernuzzi M; Raggi P; Montanari L; Pregnolato F; Pavanetto F
    J Parenter Sci Technol; 1993; 47(5):265-9. PubMed ID: 8263664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of Particulate Matter in Liquid-Finished Dosage Forms.
    Duchek J; Havasi B
    PDA J Pharm Sci Technol; 2018; 72(6):608-625. PubMed ID: 29853612
    [TBL] [Abstract][Full Text] [Related]  

  • 12. II. Particulate matter levels in large-volume injections: USP XIX method.
    Wente MA
    Bull Parenter Drug Assoc; 1977; 31(4):165-9. PubMed ID: 890179
    [No Abstract]   [Full Text] [Related]  

  • 13. New particle counter for nondestructive monitoring of parenterals.
    Porter MC
    Bull Parenter Drug Assoc; 1975; 29(4):169-82. PubMed ID: 1131461
    [No Abstract]   [Full Text] [Related]  

  • 14. [Filtering effectiveness of conventional 15 m micron filters (DIN 58362) and newly developed 15 m micron and 5 m micron filters. I: Particle count].
    Walpot H; Franke RP; Burchard WG; Agternkamp C; Müller FG; Mittermayer C; Kalff G
    Infusionstherapie; 1989 Apr; 16(2):77-80. PubMed ID: 2737765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of acceptance criteria for particulate limits for small-volume parenteral products.
    Tsuji K; Lewis AR
    J Pharm Sci; 1978 Jan; 67(1):50-5. PubMed ID: 619115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A procedure to verify the lower counting limit of optical particle counters.
    Caldow R; Blesener J
    J Parenter Sci Technol; 1989; 43(4):174-9. PubMed ID: 2769524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Particulate contamination in parenterals: current issues.
    Groves MJ
    Boll Chim Farm; 1991 Oct; 130(9):347-54. PubMed ID: 1799429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Particulate matter in four reconstituted cephalosporin injections.
    Kilarski DJ; Visconti JA; Frank SG
    Am J Hosp Pharm; 1983 Apr; 40(4):619-23. PubMed ID: 6846372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new coincidence model for single particle counters, Part II: Advances and applications.
    Knapp JZ; Lieberman A; Abramson LR
    PDA J Pharm Sci Technol; 1994; 48(5):255-92. PubMed ID: 8000900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.